13 August 2018
Visiongain has launched a new pharma report Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches, Hospital & Clinics, Ambulatory Surgical Centres, Emergency Service Centres, Home Care Settings
Combination products are being increasingly used in patients suffering from chronic disorders such as cardiac disease, cancer, diabetes, and multiple sclerosis among others. Owing to these products, a new dynamic has been initiated in the medical product development, regulatory approval as well as corporate interaction. Over the last decade, various regulatory agencies have developed numerous competences and regulations due to the rising integration of drugs and devices occurring in the latest generation of combination products.
The lead analyst of the report commented “the Drug-Device combination market is driven by initiatives from governments and NGOs in support of drug delivery implants, a rise in the usage of minimally invasive surgeries, technological innovations and advancements, and increasing prevalence of chronic disorders. However, regulatory challenges pertaining to recall of products due to adverse effects, technical challenges related to drug delivery and higher cost of the products are some of the factors hampering the growth of the Drug-Device combination market.”
Leading companies featured in the report include Medtronic, Boston Scientific Corporation, Stryker Corporation, Ethicon Inc, C.R. Bard Inc., Medline Industries Inc., Mylan Inc., Terumo Corporation, Pinnacle Biologics Inc., and W. L. Gore & Associates, Inc.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.
03 July 2020
Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
03 July 2020
With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.
01 July 2020
The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.